Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C

TA200 Hepatitis C - peginterferon alfa and ribavirin: review decision - December 2013 information  

TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive ^{PDF 111.64 KB} 20 December 2013  

TA200 Hepatitis C - peginterferon alfa and ribavirin: review proposal - October 2013 information  

TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - provisional matrix of stakeholders ^{PDF 100.31 KB} 14 October 2013  

TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix B - GE Proposal Paper September 2013 ^{PDF 534.1 KB} 14 October 2013  

200th NICE technology appraisal guidance to help tackle growing hepatitis C problem: press release information  

2010/133 200th NICE technology appraisal guidance to help tackle growing hepatitis C problem ^{PDF 77.86 KB} 06 December 2013  

Hepatitis C - peginterferon alfa and ribavirin: final appraisal determination information  

Hepatitis C - peginterferon alfa and ribavirin: final appraisal determination ^{PDF 212.31 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: comments on the ACD received from the public through the NICE website ^{PDF 12.99 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: response to consultee, commentator and public comments on the ACD and comments from website consultation ^{PDF 57.19 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: final appraisal determination - consultee and commentator comments on the ACD  

Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Department of Health ^{PDF 39.13 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - MSD/Schering Plough ^{PDF 10.43 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - NHS Quality Improvement Scotland ^{PDF 16.33 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Roche ^{PDF 38.97 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Royal College of Nursing ^{PDF 22.66 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Royal College of Pathologists ^{PDF 63.58 KB} 09 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: consultee and commentator comments on the ACD - Southampton Health Technology Assessment Centre ^{PDF 16.8 KB} 12 August 2010  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation document information  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation: evaluation report  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation: overview ^{PDF 212.17 KB} 26 May 2010  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation: assessment report ^{PDF 1.9 MB} 26 May 2010  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation: consultee and commentator comments on the assessment report  

Consultee and commentator comments on the assessment report: Department of Health ^{PDF 39.8 KB} 26 May 2010  

Consultee and commentator comments on the assessment report: NHS Quality Improvement Scotland ^{PDF 31.41 KB} 26 May 2010  

Consultee and commentator comments on the assessment report: Royal College of Nursing ^{PDF 43.91 KB} 26 May 2010  

Consultee and commentator comments on the assessment report: Royal College of Physicians ^{PDF 95.82 KB} 26 May 2010  

Consultee and commentator comments on the assessment report: Roche ^{PDF 107.21 KB} 26 May 2010  

Consultee and commentator comments on the assessment report: Schering-Plough ^{PDF 359.13 KB} 26 May 2010  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation: non-manufacturer submissions  

Non-manufacturer submissions: Hepatitis C Trust ^{PDF 42.82 KB} 26 May 2010  

Non-manufacturer submissions: Royal College of Physicians and British Society of Gastroenterology ^{PDF 102.66 KB} 26 May 2010  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation: manufacturer submissions (executive summary only)  

Manufacturer submissions (executive summary only): Roche ^{PDF 65.13 KB} 26 May 2010  

Manufacturer submissions (executive summary only): Schering-Plough ^{PDF 66.29 KB} 26 May 2010  

Hepatitis C - peginterferon alfa and ribavirin: appraisal consultation: expert written personal statements  

Expert written personal statements: Dusheikp ^{PDF 43.34 KB} 26 May 2010  

Expert written personal statements: Gore ^{PDF 16.89 KB} 26 May 2010  

Expert written personal statements: Jose ^{PDF 62.39 KB} 26 May 2010  

Expert written personal statements: Thomas ^{PDF 10.17 KB} 26 May 2010  

Hepatitis C - peginterferon alfa and ribavirin: assessment report ^{PDF 1.49 MB} 28 April 2010  

Hepatitis C - peginterferon alfa and ribavirin: final protocol ^{PDF 122.64 KB} 17 July 2009  

Hepatitis C - peginterferon alfa and ribavirin: response to consultee and commentator comments on provisonal matrix ^{PDF 18.39 KB} 19 May 2009  

Hepatitis C - peginterferon alfa and ribavirin: response to consultee and commentator comments on the draft scope ^{PDF 67.13 KB} 19 May 2009  

Hepatitis C - peginterferon alfa and ribavirin: final scope ^{PDF 35.19 KB} 19 May 2009  

Hepatitis C - peginterferon alfa and ribavirin: provisional matrix of consultee and commentators ^{PDF 37.75 KB} 23 March 2009  

Hepatitis C - peginterferon alfa and ribavirin: draft scope ^{PDF 44.97 KB} 23 March 2009